Upstream Bio Inc.

This study continues testing verekitug (UPB-101) in adults with severe asthma who finished the earlier VALIANT trial. Researchers want to understand the long-term safety and effectiveness of this medication over an extended period. The study tracks asthma attacks, breathing tests…

This study is testing an investigational drug called verekitug (UPB-101) for adults with severe asthma. The main goal is to see if regular injections can reduce the number of serious asthma flare-ups that require emergency care or steroid treatment. Researchers will also check if…